Mapping Alzheimer's disease heterogeneity with molecular imaging biomarkers
{{output}}
Background: Alzheimer's disease (AD) is neuropathologically defined by the buildup of misfolded proteins such as extracellular amyloid-β (Aβ) and intracellular tau neurofibrillary tangles. AD also extends beyond these patholog... ...